Related Experiment Videos
Reply to the letter to the editor 'patients' preference and informed consent' by Pumo et al
1Department of Medical Oncology, University Hospital Jean Minjoz, Besançon, France.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
A propensity score-weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer.
Breast cancer research and treatment·2022
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
[Diffusion prophylactic axillary irradiation in breast cancer - Literature review].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2021
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Editorial Summary of the Special Issue: Healthcare Practice in Community.
Healthcare (Basel, Switzerland)·2026
[Ambiguities of medicine in the face of forms of death].
Medecine sciences : M/S·2026
Human preferences are susceptible to covertly misaligned AI advice.
Proceedings of the National Academy of Sciences of the United States of America·2026
Reckoning with statistics' eugenicist origins: Intersectional MAIHDA and the queering of quantitative methods.
Social science & medicine (1982)·2026